Xoma Corp $3.91

up +0.03


1/8/2014 04:00 PM  |  NASDAQ : XOMA  
Industries : Drugs / Biotechnology

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
7/15/2014Varian JohnCEO-10,000$4.03-3.38%
7/15/2014Varian JohnCEO10,000$1.243.50%
7/01/2014SCANNON PATRICK J MD PHDExec. VP & CSO-5,000$4.68-5.46%
6/16/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-11,580$4.54-13.85%
6/16/2014Varian JohnCEO-10,000$4.54-3.38%
6/16/2014Varian JohnCEO10,000$1.243.50%
5/28/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-1,785$4.22-2.09%
5/15/2014Varian JohnCEO-10,000$3.55-3.38%
5/15/2014Varian JohnCEO10,000$1.243.50%
5/13/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-10,000$3.84-11.02%
3/18/2014KURLAND FREDCFO & VP Finance-5,915$6.32-8.63%
3/18/2014Varian JohnCEO-21,329$6.32-6.95%
3/18/2014Neal James RVP Business Development-2,671$6.32-1.73%
3/18/2014Klein ThomasChief Commercial Officer-257$6.32-0.58%
3/18/2014Klein ThomasChief Commercial Officer-30,708$6.32-24.79%
3/18/2014SCANNON PATRICK J MD PHDExec. VP & CSO-3,419$6.32-3.60%
3/18/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-4,661$6.32-5.54%
3/18/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-6,988$6.32-7.15%
3/18/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-6,000$6.31-6.20%
3/18/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO6,000$3.046.61%
3/17/2014Varian JohnCEO-10,000$6.03-3.57%
3/17/2014Varian JohnCEO10,000$1.243.70%
2/18/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO6,000$3.04185.87%
2/18/2014Varian JohnCEO10,000$1.246.72%
2/18/2014Varian JohnCEO-10,000$7.55-6.30%
2/18/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-6,000$7.55-65.02%
1/21/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-5,694$8.27-63.82%
1/21/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO5,694$3.04176.39%
1/21/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-306$8.27-8.66%
1/15/2014Varian JohnCEO10,000$1.246.72%
1/15/2014Varian JohnCEO-10,000$8.28-6.30%
1/09/2014SCANNON PATRICK J MD PHDExec. VP & CSO-20,000$8.00-32.25%
1/09/2014SCANNON PATRICK J MD PHDExec. VP & CSO20,000$1.6947.60%
12/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-6,000$5.67-62.93%
12/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO6,000$3.04169.78%
12/16/2013Varian JohnCEO10,000$1.246.72%
12/16/2013Varian JohnCEO-10,000$5.44-6.30%
12/02/2013SCANNON PATRICK J MD PHDExec. VP & CSO-16,665$6.00-28.40%
12/02/2013SCANNON PATRICK J MD PHDExec. VP & CSO16,665$1.6939.66%
12/02/2013SCANNON PATRICK J MD PHDExec. VP & CSO-3,335$6.00-7.35%
12/02/2013SCANNON PATRICK J MD PHDExec. VP & CSO3,335$1.697.94%
11/27/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-4,696$4.54-57.06%
11/27/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO4,696$3.04132.88%
11/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO1,304$2.3636.90%
11/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-1,304$4.08-26.95%
11/15/2013Varian JohnCEO10,000$1.246.72%
11/15/2013Varian JohnCEO-10,000$4.13-6.30%
11/13/2013KURLAND FREDCFO & VP Finance-12,331$3.91-35.83%
11/13/2013SCANNON PATRICK J MD PHDExec. VP & CSO-8,346$3.91-16.57%
11/13/2013Varian JohnCEO-52,477$3.91-26.08%
11/13/2013Varian JohnCEO-2,455$3.91-2.28%
10/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-746$4.71-7.82%
10/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO746$2.368.49%
10/15/2013Varian JohnDirector and CEO-10,000$4.60-8.85%
10/15/2013Varian JohnDirector and CEO10,000$1.249.71%
9/30/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO459$4.275.51%
9/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-6,000$4.53-41.87%
9/16/2013Varian JohnDirector and CEO-10,000$4.59-8.85%
9/16/2013Varian JohnDirector and CEO10,000$1.249.71%
8/19/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-6,000$3.74-29.51%
8/19/2013BAKER BROS. ADVISORS LPSenior Executive Officer882,323$3.6245.31%
8/19/2013BAKER BROS. ADVISORS LPSenior Executive Officer21,410$3.624.38%
8/19/2013BAKER BROS. ADVISORS LPSenior Executive Officer1,854,058$3.6210.35%
8/15/2013Varian JohnDirector and CEO-10,000$3.92-8.85%
8/15/2013Varian JohnDirector and CEO10,000$1.249.71%
8/14/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-10,520$3.86-34.10%
8/14/2013SCANNON PATRICK J MD PHDExec. VP & CSO-6,002$3.86-17.80%
8/14/2013KURLAND FREDCFO & VP Finance-7,498$3.86-23.04%
8/14/2013Varian JohnDirector and CEO-51,647$3.86-85.97%
7/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO3,252$3.0479.30%
7/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-3,252$4.71-44.23%
7/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-2,748$4.71-40.12%
7/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO2,748$2.3667.01%
7/15/2013Varian JohnDirector and CEO-10,000$4.81-14.27%
7/15/2013Varian JohnDirector and CEO10,000$1.2416.64%
6/28/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO567$3.4516.04%
6/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO3,130$2.3648.88%
6/17/2013Varian JohnDirector and CEO10,000$1.2416.64%
6/11/2013SCANNON PATRICK J MD PHDExec. VP & CSO10,000$1.6957.31%
5/29/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-1,797$4.16-21.91%
5/28/2013WYSZOMIERSKI JACK LDirector2,800$2.6962.24%
5/20/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO785$2.368.97%
5/20/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-785$4.16-8.23%
5/15/2013Varian JohnDirector and CEO10,000$1.2416.64%
5/14/2013SCANNON PATRICK J MD PHDExec. VP & CSO10,000$1.6957.31%
3/28/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO1,498$3.3211.30%
3/19/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-6,990$3.29-34.53%
12/31/2012RUBIN PAUL DSr. VP Clinical Dev. & CMO833$2.2869.24%
11/14/2012KURLAND FREDCFO & VP Finance-9,111$2.56-40.32%
11/14/2012SCANNON PATRICK J MD PHDExecutive Vice President-8,773$2.56-33.46%
11/14/2012Varian JohnDirector and CEO-38,773$2.56-39.22%
11/14/2012Varian JohnDirector and CEO-1,814$2.56-1.80%
10/29/2012BAKER JULIANSenior Executive Officer4,282,419$3.0031.47%
10/29/2012BAKER JULIANSenior Executive Officer103,608$3.0028.76%
10/29/2012BAKER JULIANSenior Executive Officer336,639$3.0021.23%
9/28/2012RUBIN PAUL DSr. VP Clinical Dev. & CMO542$3.5182.00%
3/30/2012RUBIN PAUL DVP Clinical Dev. & CMO1,229$2.6346.24%
11/11/2011VAN NESS W DENMANDirector-698$1.60-21.16%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (XOMA), click here.
Trading Center